Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.52 |
| ▸ | IDO1 | P14902 | 1/20 | 0.37 |
| ▸ | TDO2 | P48775 | 1/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | ALPL | P05186 | 1/20 | 0.36 |
| ▸ | ALPI | P09923 | 1/20 | 0.36 |
| ▸ | ALPG | P10696 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | NOS3 | P29474 | 2/20 | 0.35 |
| ▸ | NOS1 | P29475 | 2/20 | 0.35 |
| ▸ | NOS2 | P35228 | 2/20 | 0.35 |
| ▸ | PMM2 | O15305 | 1/20 | 0.35 |
| ▸ | MPI | P34949 | 1/20 | 0.35 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.34 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29463737 | 1.00 | CYP3A4 (0.52) | CYP3A4IDO1TDO2TRPA1MEN1 | |
| SCHEMBL8101565 | 0.88 | CYP3A4 (0.42) | CYP3A4IDO1TDO2TRPA1MEN1 | |
| SCHEMBL17847475 | 0.83 | CYP3A4 (0.45) | CYP3A4IDO1TDO2TRPA1MEN1 | |
| SCHEMBL8943320 | 0.82 | CYP3A4 (0.42) | CYP3A4IDO1TDO2TRPA1MEN1 | |
| SCHEMBL15431 | 0.82 | CYP3A4 (0.64) | CYP3A4TRPA1MEN1KMT2ANPC1 | |
| SCHEMBL29395383 | 0.82 | CYP3A4 (0.64) | CYP3A4TRPA1MEN1KMT2ANPC1 | |
| SCHEMBL2169198 | 0.80 | CYP3A4 (0.52) | CYP3A4TRPA1GABRA1GABRB2ALDH1A1 | |
| SCHEMBL11436625 | 0.80 | MEN1 (0.42) | CYP3A4IDO1TDO2MEN1KMT2A | |
| Water SCHEMBL28526910 | 0.79 | CYP3A4 (0.61) | CYP3A4TRPA1MEN1KMT2ANPC1 | |
| SCHEMBL30244709 | 0.79 | CYP3A4 (0.61) | CYP3A4TRPA1MEN1KMT2ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 665 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111471171-B | Arylsulfonic acid intermediate, preparation method thereof and application of aryl sulfonic acid intermediate in synthesizing low-temperature-sensitivity additive for concrete | 江苏苏博特新材料股份有限公司 | 2023-07-18 | — | — | CN | claimed |
| CN-111100732-B | Soap urethane lubricating grease and preparation method thereof | 中国石油化工股份有限公司 | 2022-10-21 | — | — | CN | claimed |
| CN-111471171-A | Aryl sulfonic acid intermediate, preparation method thereof and application thereof in synthesizing low-temperature-sensitivity additive for concrete | 江苏苏博特新材料股份有限公司 | 2020-07-31 | — | — | CN | claimed |
| CN-111100732-A | Soap urethane lubricating grease and preparation method thereof | 中国石油化工股份有限公司 | 2020-05-05 | — | — | CN | claimed |
| CN-107176925-B | Synthesis method of polysubstituted imidazoline-2, 4-diketone compound | 湖北科技学院 | 2020-04-28 | — | — | CN | claimed |
| CN-107176925-A | A kind of synthetic method of the cyclohexadione compounds of polysubstituted imidazoline 2,4 | 湖北科技学院 | 2017-09-19 | — | — | CN | claimed |
| CN-105153317-A | Synthetic method for cellulose derivative with large volume liquid crystal unit side group | UNIV HARBIN ENG | 2015-12-16 | — | — | CN | claimed |
| US-8222314-B2 | Phenyl isocyanate-based urethane acrylates, processes for producing and methods of using the same | BAYER MATERIALSCIENCE AG (DE) | 2012-07-17 | — | — | US | claimed |
| CN-101704773-A | Phenyl isocyanate-based urethane acrylates, processes for making and methods of using the same | BAYER MATERIALSCIENCE AG | 2010-05-12 | — | — | CN | claimed |
| EP-2154129-A1 | Phenylisocyanate based urethanacrylate with high refraction index | Bayer MaterialScience AG (DE) | 2010-02-17 | — | — | EP | claimed |
| EP-2154128-A1 | Phenylisocyanate based urethanacrylates with high refraction index | Bayer MaterialScience AG (DE) | 2010-02-17 | — | — | EP | claimed |
| US-20100036013-A1 | PHENYL ISOCYANATE-BASED URETHANE ACRYLATES, PROCESSES FOR PRODUCING AND METHODS OF USING THE SAME | BAYER MATERIALSCIENCE AG (DE) | 2010-02-11 | — | — | US | claimed |
| US-20090216006-A1 | COVALENTLY BOUND POLYSACCHARIDE-BASED CHIRAL STATIONARY PHASES AND METHOD FOR THEIR PREPARATION | XU HUI | 2009-08-27 | — | — | US | claimed |
| EP-1425277-B1 | UREA-COMPOUNDS ACTIVE AS VANILLOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PAIN | SMITHKLINE BEECHAM PLC (GB) | 2009-01-07 | — | — | EP | claimed |
| EP-1377589-B1 | OXAZOLYL-PYRAZOLE DERIVATIVES AS KINASE INHIBITORS | PHARMACIA ITALIA SPA (IT) | 2005-09-07 | — | — | EP | claimed |
| US-20260146238-A1 | UREA-BASED ICE RECRYSTALLIZATION INHIBITOR COMPOUNDS AND COMPOSITIONS, AND USES THEREOF FOR CRYOPRESERVATION | PanTHERA CryoSolutions Inc. (CA) | 2026-05-28 | — | — | US | disclosed |
| CN-122079899-A | Application of pharmaceutical composition in preparation of medicines for preventing or treating diseases related to Sirttail 7 protein | — | 2026-05-26 | — | — | CN | disclosed |
| US-3966683-A | Process for the preparation of compounds which contain hydantoin groups | BAYER AKTIENGESELLSCHAFT (DT) | 1976-06-29 | — | — | US | disclosed |
| US-3956237-A | HINDERED UREA OR THIOUREA | THE DOW CHEMICAL COMPANY (US) | 1976-05-11 | — | — | US | disclosed |
| US-3939122-A | Process for the preparation of compounds which contain hydantoin rings | BAYER AKTIENGESELLSCHAFT (DT) | 1976-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260146238-A1 | UREA-BASED ICE RECRYSTALLIZATION INHIBITOR COMPOUNDS AND COMPOSITIONS, AND USES THEREOF FOR CRYOPRESERVATION | RCC1, HNRNPC, CPT1A | CYP3A4 1007/4885IDO1 1607/4885TDO2 4082/4885 |
| US-20100036013-A1 | PHENYL ISOCYANATE-BASED URETHANE ACRYLATES, PROCESSES FOR PRODUCING AND METHODS OF USING THE SAME | GRHPR, CBR1, C1S | CYP3A4 783/4885IDO1 2439/4885TDO2 479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.